The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.
about
Summary of emerging targets in anal cancer: the case for an immunotherapy based-approachCetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal.Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.A combined modality therapeutic approach to metastatic anal squamous cell carcinoma with systemic chemotherapy and local therapy to sites of disease: case report and review of literature.Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.Pharmacotherapy of Anal Cancer.A Patient with HIV-Associated Metastatic Anal Squamous Cell Carcinoma Receiving Multimodality Therapy with Curative Intent: Case Report and Review of the Literature.Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report.Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting.Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia
P2860
Q28080081-EE75F590-9A5D-49EC-BC3B-1BF47F206326Q36062576-B32F7B43-024F-4AD6-999C-8F78B67A1A7BQ36685452-9239A580-30D5-4EB1-B75E-C796421B41D8Q36936998-DF5E61EC-FB24-40E4-925E-7016F568918DQ38405569-78D769D4-4BAF-4E91-8373-24A92D10A46DQ38647761-1C71D7BE-AE3F-4E24-9C25-11521B69B3ABQ38767968-0A907918-07D6-4E79-8CCB-6DF042A2B522Q40103314-E3160A23-7D5F-459B-A482-C58F465DA861Q40814170-97086D00-E128-4878-978C-ECA9621473A4Q47098450-2A501F84-3136-4DEA-BDB3-0FA7580C3863Q47156788-051C7329-2C3B-45F9-89BE-59AFDA183E72Q52905730-4F8BD665-A73B-42BA-A0F9-0A228057D52AQ54116465-B96A84E8-E2A6-4C47-9B37-82DAA3147A1AQ55278986-15A4A7D7-263D-451F-A0B2-FA38E1B88510Q58548044-527D32AA-738E-48E8-90BD-29BC5652B882
P2860
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of systemic chemother ...... l carcinoma of the anal canal.
@ast
The role of systemic chemother ...... l carcinoma of the anal canal.
@en
The role of systemic chemother ...... l carcinoma of the anal canal.
@nl
type
label
The role of systemic chemother ...... l carcinoma of the anal canal.
@ast
The role of systemic chemother ...... l carcinoma of the anal canal.
@en
The role of systemic chemother ...... l carcinoma of the anal canal.
@nl
prefLabel
The role of systemic chemother ...... l carcinoma of the anal canal.
@ast
The role of systemic chemother ...... l carcinoma of the anal canal.
@en
The role of systemic chemother ...... l carcinoma of the anal canal.
@nl
P2093
P2860
P356
P1433
P1476
The role of systemic chemother ...... l carcinoma of the anal canal.
@en
P2093
Aki Ohinata
Christopher H Crane
George J Chang
Jane E Rogers
Jonathan K Phillips
Miguel Rodriguez-Bigas
Prajnan Das
Priyanka Pathak
Robert A Wolff
P2860
P304
11133-11142
P356
10.18632/ONCOTARGET.2563
P407
P577
2014-11-01T00:00:00Z